FDA Approves Peginterferon Alfa-2b (Sylatron(tm)), For Adjuvant Melanoma
Links shared publicly online about this topic.
- 397total visits
FDA Approves Peginterferon Alfa-2b (Sylatron(tm)), For Adjuvant Melanoma
View full resource at medicalnewstoday.com
Tags: Cancer, Skin Cancer, Melanoma, Diet and Nutrition, Drug, FDA, Safety
Most Recently Shared on April 1, 2011 at 11:10 am By:
FDA Approves Peginterferon Alfa-2b (Sylatron(tm)), For Adjuvant Melanoma http://t.co/UDgxhXB via @mnt_skincancer
Also Shared By:
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
drugs.com — “Sylatron (peginterferon alfa-2b) is used for the adjuvant treatment of melanoma. Includes Sylatron side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 14, 2011 at 12:11 am By:
Drugs and Devices OW OW Health
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma... http://bit.ly/fpTNTP #drug
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
drugs.com — “Sylatron (peginterferon alfa-2b) is used for the adjuvant treatment of melanoma. Includes Sylatron side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 13, 2011 at 11:43 pm By:
FDA Approves Merck's Sylatron (peginterferon alfa-2b) for the Adjuvant Treatment of Melanoma - http://bit.ly/f4t9Dr
FDA Approves Peginterferon Alfa-2b for Melanoma : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on April 13, 2011 at 9:44 pm By:
Bob Finn - Medical News Net Health News
For node+ melanoma, FDA approves peginterferon alfa-2b, 1st adjuvant therapy approved in >15 yrs. @aliciaault reports. http://bit.ly/fzGy1r
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on April 12, 2011 at 1:33 pm By:
eyeonfda Health Lawyer and Pharma
FDA Approves Merck's SYLATRONâ„¢ (peginterferon alfa-2b) for Injection, Adjuvant Treatment for Melanoma - http://ow.ly/4yq3k
GEN | Industry Updates: FDA Approves Merck's SYLATRON™ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement
genengnews.com — “GEN | Industry Updates: FDA Approves Merck's SYLATRON™ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement” View full resource at genengnews.com
Most Recently Shared on April 12, 2011 at 11:43 am By:
Dr. Anthony Blash Doctor, Pharmacist, and PharmD
FDA Approves Merck's SYLATRONâ„¢ (peginterferon alfa-2b) for Injection, a New Adjuvant Treatment fo... http://bit.ly/gr7yUC (via @news360app)
Advertisement
MNT Skin Cancer
@mnt_skincancer
FDA Approves Peginterferon Alfa-2b (Sylatron(tm)), For Adjuvant Melanoma http://mnt.to/3T34 #skincancer #melanoma
1 year ago...